Skip to main content

Table 2 Comparison of clinical characteristic of at baseline between cases failed conservative treatment (Group A) and continued uterine conservative treatment (Group B)

From: Characterization of patients that can continue conservative treatment for adenomyosis

 

Group A (n = 28)

Group B (n = 26)

p value

Age†

43 (33–53)

37 (27–46)

< 0.001

Gravida†

2 (0–6)

0 (0–3)

< 0.001

Parity†

2 (0–3)

0 (0–2)

< 0.001

Multipara†

23 (82.1%)

11 (42.3%)

< 0.001

Long axis diameter (cm)*

11.1 (7.6–17.7)

9.0 (6.4–13.0)

< 0.001

Short axis diameter (cm)*

7.7 (4.7–12.9)

6.0 (3.5–9.9)

0.002

Transvers diameter (cm)*

8.0 (4.1–14.2)

6.6 (3.7–9.2)

0.012

Muscle layer thickness (cm)*

4.6 (2.5–7.3)

3.5 (1.3–6.4)

0.018

Type IV adenomyosis*

18 (64.3%)

10 (38.5%)

0.059

Another of endometriosis*

11 (39.3%)

13 (50.0%)

0.766

  1. *The Mann–Whitney U test, †χ2 test